New Bubbleroom Sweden AB
STO:BBROOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
New Bubbleroom Sweden AB
STO:BBROOM
|
SE |
|
Samrat Pharmachem Ltd
BSE:530125
|
IN |
|
Morningstar Japan KK
TSE:4765
|
JP |
|
Ariston Holding NV
MIL:ARIS
|
IT |
|
Trust Holdings Inc
TSE:3286
|
JP |
|
Arriyadh Development Company SJSC
SAU:4150
|
SA |
|
Iron Horse Acquisitions Corp
NASDAQ:IROH
|
US |
|
L
|
Lam Thao Fertilizers and Chemicals JSC
VN:LAS
|
VN |
|
W
|
Wodkan Przedsiebiorstwo Wodociagow i Kanalizacji SA
WSE:WOD
|
PL |
|
VVC Exploration Corp
XTSX:VVC
|
CA |
|
T&K Toka Co Ltd
TSE:4636
|
JP |
|
E
|
EFC (I) Ltd
BSE:512008
|
IN |
|
Calima Energy Ltd
ASX:CE1
|
AU |
|
Dynex Capital Inc
NYSE:DX
|
US |
|
A
|
Atour Lifestyle Holdings Ltd
NASDAQ:ATAT
|
CN |
|
A
|
Argeo AS
OSE:ARGEO
|
NO |
|
Epigral Ltd
NSE:EPIGRAL
|
IN |
|
Thomas Cook (India) Ltd
NSE:THOMASCOOK
|
IN |
|
Oxpay Financial Ltd
SGX:TVV
|
SG |
|
Hanwha Solutions Corp
KRX:009830
|
KR |
|
TransAlta Corp
TSX:TA
|
CA |
|
I
|
IFirma SA
WSE:IFI
|
PL |
|
Sika AG
F:SIKA
|
CH |
|
SpiderPlus & Co
TSE:4192
|
JP |
Cash Flow Statement
Cash Flow Statement
New Bubbleroom Sweden AB
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(3)
|
(6)
|
(5)
|
(2)
|
(19)
|
(25)
|
(25)
|
(28)
|
(27)
|
(29)
|
(32)
|
(29)
|
(22)
|
(17)
|
(14)
|
(15)
|
(19)
|
(21)
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
3
|
4
|
4
|
5
|
7
|
7
|
8
|
9
|
9
|
9
|
10
|
10
|
10
|
10
|
10
|
|
| Other Non-Cash Items |
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(3)
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Cash Interest Paid |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
|
| Change in Working Capital |
4
|
0
|
(2)
|
22
|
(49)
|
(50)
|
(34)
|
(28)
|
4
|
32
|
27
|
19
|
1
|
8
|
(7)
|
(7)
|
17
|
0
|
|
| Cash from Operating Activities |
3
N/A
|
(4)
N/A
|
(5)
-35%
|
22
N/A
|
(65)
N/A
|
(74)
-15%
|
(53)
+29%
|
(48)
+10%
|
(14)
+70%
|
15
N/A
|
6
-58%
|
2
-66%
|
(8)
N/A
|
3
N/A
|
(9)
N/A
|
(11)
-14%
|
10
N/A
|
(10)
N/A
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(1)
|
(13)
|
(13)
|
(29)
|
(40)
|
(44)
|
(46)
|
(34)
|
(22)
|
(7)
|
(4)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(1)
|
|
| Other Items |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
(2)
|
(3)
|
(5)
|
|
| Cash from Investing Activities |
(2)
N/A
|
(14)
-639%
|
(14)
-2%
|
(32)
-120%
|
(43)
-36%
|
(47)
-10%
|
(50)
-6%
|
(38)
+25%
|
(25)
+33%
|
(9)
+66%
|
(6)
+32%
|
(1)
+84%
|
(1)
+14%
|
(0)
+39%
|
0
N/A
|
(2)
N/A
|
(3)
-36%
|
(5)
-94%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
2
|
145
|
151
|
151
|
151
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
5
|
5
|
16
|
15
|
21
|
22
|
8
|
8
|
(5)
|
(8)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(4)
|
(4)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
150
+8 141%
|
156
+4%
|
167
+7%
|
166
-1%
|
27
-83%
|
22
-19%
|
8
-65%
|
8
-1%
|
(5)
N/A
|
(8)
-46%
|
(6)
+23%
|
(6)
N/A
|
(6)
+1%
|
(6)
+1%
|
(6)
-2%
|
(4)
+26%
|
(4)
+5%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Net Change in Cash |
3
N/A
|
132
+4 627%
|
136
+3%
|
158
+16%
|
58
-63%
|
(94)
N/A
|
(81)
+14%
|
(77)
+4%
|
(32)
+59%
|
1
N/A
|
(7)
N/A
|
(5)
+35%
|
(15)
-227%
|
(4)
+75%
|
(15)
-311%
|
(19)
-22%
|
3
N/A
|
(21)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
2
N/A
|
(16)
N/A
|
(18)
-10%
|
(6)
+64%
|
(105)
-1 532%
|
(118)
-12%
|
(99)
+16%
|
(82)
+17%
|
(37)
+55%
|
8
N/A
|
2
-75%
|
2
-5%
|
(9)
N/A
|
2
N/A
|
(9)
N/A
|
(11)
-14%
|
10
N/A
|
(10)
N/A
|
|